[Ever-Glory Reports Third Quarter 2009 Financial Results -- 3Q09 Gross Marginreased 420 Basis Points YoY to 18.6% -- -- 3Q09 Netomereased 200.3% to $1.9 million or $0.14 per diluted share Nanjing, China, November 9, 2009 because of the global economic slowdown . During the third quarter 2009, netles decreased 21.8% to $24.9 million from $31.9]
[Biostar Pharmaceuticals, Announces Record Third Quarter 2009 Financial Results -- Q3 2009 revenuereased 106.3% to $15.6 million; Q3 Gross Margins of 77.0% -- Q3 2009 netomereased 459.2% to $3.1 million with EPS of $0.13 -- Revenue for the first nine monthsreased 52.5 % to $36.2 million; netomereased 112.9% to $8.8 million with EPS of $0.37]
[Ever-Glory Reports Third Quarter 2009 Financial Results -- 3Q09 Gross Marginreased 420 Basis Points YoY to 18.6% -- -- 3Q09 Netomereased 200.3% to $1.9 million or $0.14 per diluted share Nanjing, China, November 9, 2009 because of the global economic slowdown . During the third quarter 2009, netles decreased 21.8% to $24.9 million from $31.9]
[American Lorain Corporation Announces JUNAN COUNTY, China, Nov. 12 /PRNewswire-Asia-FirstCall/ -- American Lorain Corporation (NYSE Amex: ALN) ("American Lorain," or the "Company"), an international processed foods company based in Shandong Province, People's Republic of China ("PRC"), announced its financial results for the third quarter of fiscal year 2009 ended September 30, 2009. The Company will hold a conference call on] [____________________________ FORM 8-K CURRENT REPORT November 12, 2009 Date of Report (Date of Earliest Event Reported): AMERICAN LORAIN CORPORATION Delaware (State of Incorporation) 001-34449 87-0430320 Shandong, China 276600 Beihuan Road (86) 539-7318818 £ £ £ £ Item 2.02 Results of Operations and Financial Condition.]
[American Lorain Corporation Announces JUNAN COUNTY, China, Nov. 12 /PRNewswire-Asia-FirstCall/ -- American Lorain Corporation (NYSE Amex: ALN) ("American Lorain," or the "Company"), an international processed foods company based in Shandong Province, People's Republic of China ("PRC"), announced its financial results for the third quarter of fiscal year 2009 ended September 30, 2009. The Company will hold a conference call on] [____________________________ FORM 8-K CURRENT REPORT November 12, 2009 Date of Report (Date of Earliest Event Reported): AMERICAN LORAIN CORPORATION Delaware (State of Incorporation) 001-34449 87-0430320 Shandong, China 276600 Beihuan Road (86) 539-7318818 £ £ £ £ Item 2.02 Results of Operations and Financial Condition.]
[SORL Auto Parts Reports Third Quarter 2009 Financial Results - EPS of $0.21 in the 2009 third quarter - ZHEJIANG, China, November 13, 2009 -- SORL Auto Parts, Inc. (Nasdaq: SORL) (“SORL” or “The Company”), a leading manufacturer and distributor of commercial vehicle air brake systems as well as related auto parts in China, announced financial results for the third] []
[SORL Auto Parts Reports Third Quarter 2009 Financial Results - EPS of $0.21 in the 2009 third quarter - ZHEJIANG, China, November 13, 2009 -- SORL Auto Parts, Inc. (Nasdaq: SORL) (“SORL” or “The Company”), a leading manufacturer and distributor of commercial vehicle air brake systems as well as related auto parts in China, announced financial results for the third] []
[Biostar Pharmaceuticals, Announces Record Third Quarter 2009 Financial Results -- Q3 2009 revenuereased 106.3% to $15.6 million; Q3 Gross Margins of 77.0% -- Q3 2009 netomereased 459.2% to $3.1 million with EPS of $0.13 -- Revenue for the first nine monthsreased 52.5 % to $36.2 million; netomereased 112.9% to $8.8 million with EPS of $0.37]
[Skystar to Present at the Brean Murray Carret & Co. 2009 China Growth Conference XI'AN, CHINA — November 11 , 2009 — Skystar Bio-Pharmaceutical Company skystar@tpg-ir.com To request a one-on-one meeting or to be added to Skystar’s email list, please contact Brandi Floberg at About Skystar Bio-Pharmaceutical Company http://www.skystarbio-pharmaceutical.com Skystar is a China-based developer and distributor of veterinary healthcare and]
[Skystar to Present at the Brean Murray Carret & Co. 2009 China Growth Conference XI'AN, CHINA — November 11 , 2009 — Skystar Bio-Pharmaceutical Company skystar@tpg-ir.com To request a one-on-one meeting or to be added to Skystar’s email list, please contact Brandi Floberg at About Skystar Bio-Pharmaceutical Company http://www.skystarbio-pharmaceutical.com Skystar is a China-based developer and distributor of veterinary healthcare and]
